HomeALIVUS • NSE
add
Alivus Life Sciences Ltd
Previous close
₹1,142.60
Day range
₹1,115.00 - ₹1,155.20
Year range
₹850.00 - ₹1,251.00
Market cap
139.80B INR
Avg Volume
93.97K
P/E ratio
28.85
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 6.60B | 22.93% |
Operating expense | 1.84B | 40.04% |
Net income | 1.42B | 44.86% |
Net profit margin | 21.51 | 17.86% |
Earnings per share | 11.55 | 44.92% |
EBITDA | 2.08B | 48.36% |
Effective tax rate | 25.84% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.49B | 82.09% |
Total assets | 34.11B | 19.68% |
Total liabilities | 5.94B | 14.67% |
Total equity | 28.17B | — |
Shares outstanding | 122.62M | — |
Price to book | 4.97 | — |
Return on assets | — | — |
Return on capital | 17.74% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.42B | 44.86% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2011
Website
Employees
2,014
